At Sientra, we always have something noteworthy going on.
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products, Inc.
Sientra Provides Update on Manufacturing Solution
Sientra Acquires bioCorneum Advanced Silicone Gel Scar Management Therapy
Sientra Announces Return of All Products to U.S. Market
Sientra Announces Executive Management Promotions
Sientra Files Registration Statement for Proposed Initial Public Offering
Sientra and RealSelf Announce Exclusive Initiative to Deliver New Education to Women Seeking Breast Augmentation
Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer
Sientra Launches Industry's First-Ever Patient-Centric Capsular Contracture Care Program
Sientra Defeats J&J/Mentor Worldwide Lawsuit: A Victory For Free Competition, Employee Rights And Women's Health
Sientra Raises $65 Million in a Series C Financing to Support Commercialization of its FDA-Approved Silicone Breast Implants
Sientra receives FDA approval of its Silimed-brand portfolio of round and shaped silicone breast implants